According to a report by Intel Market Research, the global Livestock mRNA Vaccines Market was valued at USD 13.8 million in 2024 and is projected to grow from USD 15.3 million in 2025 to USD 28.4 million by 2032, registering a CAGR of 11.0% during the forecast period. Livestock mRNA vaccines use messenger RNA technology to provide farm animals with genetic instructions that stimulate the production of pathogen-specific proteins and trigger an immune response without exposing animals to actual viruses or bacteria. The technology is gaining attention for its ability to support faster vaccine development and adaptation against emerging livestock diseases.
Explore the full report: https://www.intelmarketresearch.com/global-livestock-mrna-vaccines-forecast-2025-2032-424-2683
Why Is Demand Increasing?
- Rising livestock disease prevalence — Outbreaks of African swine fever, avian influenza, and foot-and-mouth disease continue to create animal-health and food-security challenges. From January 2021 to August 2023, more than 1.5 million pigs and wild boars were lost to African swine fever across 50 affected countries, while the report also highlights continuing avian influenza outbreaks.
- Advances in mRNA technology — Improvements in lipid nanoparticle delivery, mRNA modification, vaccine stability, and manufacturing scalability are supporting the development of veterinary mRNA platforms. The report notes that some trials have demonstrated antibody titers 5–10 times higher than conventional vaccines.
- Faster response to emerging diseases — mRNA platforms can be rapidly customized as pathogens evolve, creating an advantage for outbreak response. The report also identifies increasing investment from pharmaceutical and animal-health companies targeting diseases such as avian influenza, African swine fever, and foot-and-mouth disease.
Veterinary Biotechnology & Animal Health Watch: mRNA Platforms Move Toward Commercialization
The livestock vaccine industry is increasingly focused on technologies that can shorten development timelines and respond to rapidly changing disease threats. mRNA platforms are being developed alongside lipid nanoparticle delivery systems, thermostable formulations, and new administration approaches. The report highlights the growing integration of mRNA vaccines with precision livestock farming, including IoT-enabled monitoring and digital tools for tracking immune responses and vaccination schedules. Regulatory activity is also evolving, with agencies developing pathways for veterinary mRNA products. Meanwhile, combination and multivalent formulations are creating opportunities to target multiple pathogens in a single vaccination program.
Segmentation Highlights
- By Livestock Type: The market is segmented into Swine (Pigs), Poultry, Cattle, Sheep & Goats, and Others.
- By Application: Applications include Infectious Disease Prevention, Production Enhancement, and Zoonotic Disease Control.
- By Technology: The market covers Conventional mRNA Vaccines, Self-amplifying mRNA Vaccines, and Nucleoside-modified mRNA Vaccines. The report specifically highlights self-amplifying mRNA technology for its enhanced immune-response potential.
- By End User: Key end users include Veterinary Hospitals, Livestock Farms, and Research Institutions.
Regional Outlook
- North America leads the global Livestock mRNA Vaccines Market, accounting for 38% of market share in 2024. The region benefits from biotechnology infrastructure, animal-health investment, research activity, and regulatory support.
- Asia-Pacific is projected to record the fastest growth, with a 13.2% CAGR through 2032. China’s expanding livestock industry and mRNA investment, together with India’s growing dairy sector and government-backed vaccination programs, support regional development.
- Europe holds a substantial market position, supported by animal-welfare regulations, sustainable livestock-farming initiatives, and mRNA development activity in Germany and France.
- South America is an emerging market, with Brazil and Argentina benefiting from large beef and poultry industries. However, economic conditions and limited local production remain challenges.
- Middle East & Africa show gradual adoption. Government-led livestock modernization in the UAE and Saudi Arabia is creating opportunities, while limited veterinary infrastructure and logistical challenges continue to constrain development.
Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/2683/global-livestock-mrna-vaccines-forecast-2025-2032-424
Why This Market Matters
Livestock mRNA vaccines are emerging as a technology platform for addressing infectious diseases that can spread rapidly through animal populations and create consequences for agricultural production and food security. Unlike conventional approaches that can require lengthy development cycles, mRNA technology offers rapid development and customization capabilities, making it relevant to diseases with evolving strains. The report identifies avian influenza, African swine fever, and foot-and-mouth disease among the major disease areas supporting interest in the technology.
Commercialization, however, remains influenced by high development costs, complex manufacturing, cold-chain requirements, regulatory uncertainty, farmer acceptance, variable immune responses across animal species and breeds, and intellectual-property considerations. The report notes that current mRNA vaccine pricing can be 3–5 times higher than conventional livestock vaccines, while strict temperature-control requirements can add to distribution costs.
Competitive Landscape
- Merck Animal Health — Identified as a leading participant, supported by its animal-health expertise, distribution network, and partnerships involving mRNA technology.
- Ceva Animal Health — Competes through animal-health development and regional collaborations, including investment in vaccine production capacity.
- Bayer — Participates in the emerging mRNA livestock vaccine landscape, with activity focused on cattle and pig applications.
- BioNTech — Brings established mRNA platform expertise into livestock applications, including collaboration with Genvax Technologies.
- Moderna — Applies its mRNA technology capabilities to livestock vaccine development, including work related to H5 avian influenza.
View the full report: https://www.intelmarketresearch.com/global-livestock-mrna-vaccines-forecast-2025-2032-424-2683
FAQ
Q: What is the current size and forecast of the Livestock mRNA Vaccines Market?
A: The global market was valued at USD 13.8 million in 2024 and is projected to reach USD 28.4 million by 2032, expanding at a CAGR of 11.0%.
Q: Which region leads the Livestock mRNA Vaccines Market?
A: North America leads the market with a 38% share in 2024, while Asia-Pacific is projected to grow at the fastest rate, with a 13.2% CAGR through 2032.
Q: What technology trends are shaping the market?
A: Key trends include self-amplifying mRNA vaccines, nucleoside-modified mRNA, combination vaccines, thermostable formulations, needle-free administration, AI-assisted vaccine design, and integration with precision livestock farming technologies.
What Does the Full Report Cover?
The full study provides a detailed assessment of the Livestock mRNA Vaccines Market across global and regional markets for 2025–2032. It covers historical and forecast market size, revenue, sales volume, pricing, market shares, and segmentation by livestock type, application, technology, end user, and region. The report also provides country-level analysis across North America, Europe, Asia, South America, and the Middle East & Africa. Competitive coverage includes company profiles, product offerings, revenue and sales, production capacity, pricing, strategic developments, partnerships, and expansions. Additional analysis examines market drivers, restraints, challenges, opportunities, supply-chain dynamics, emerging technologies, regulatory developments, and the role of AI, IoT, and other technologies where applicable.
View the complete report: https://www.intelmarketresearch.com/global-livestock-mrna-vaccines-forecast-2025-2032-424-2683
Download the free sample: https://www.intelmarketresearch.com/download-free-sample/2683/global-livestock-mrna-vaccines-forecast-2025-2032-424
Related Reports
The supplied IMR report page does not provide verified related-report URLs. No unrelated report links have been added.
About Intel Market Research
Intel Market Research, established in 2015, provides quantified market research reports covering market size, forecasts, segmentation, regional analysis, competitive landscapes, technology trends, market dynamics, and strategic insights. The company’s research is designed for manufacturers, suppliers, distributors, investors, regulators, and policymakers across global industries.
Contact Details
Website: www.intelmarketresearch.com
Asia-Pacific: +91 9169164321
Email: help@intelmarketresearch.com
